Australia markets closed

Big Pharma Split Corp. (PRM.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
14.40+0.10 (+0.70%)
At close: 02:17PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 16.64M
Enterprise value -9.41M
Trailing P/E 5.76
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)55.81
Price/book (mrq)1.05
Enterprise value/revenue 53.37
Enterprise value/EBITDA -2.45

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-3.05%
S&P500 52-week change 326.36%
52-week high 315.35
52-week low 313.20
50-day moving average 313.90
200-day moving average 314.16

Share statistics

Avg vol (3-month) 31.18k
Avg vol (10-day) 31.43k
Shares outstanding 51.16M
Implied shares outstanding 61.16M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short (30 Apr 2024) 4720
Short ratio (30 Apr 2024) 40.04
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.06%
Shares short (prior month 28 Mar 2024) 492

Dividends & splits

Forward annual dividend rate 41.24
Forward annual dividend yield 48.65%
Trailing annual dividend rate 31.24
Trailing annual dividend yield 38.65%
5-year average dividend yield 49.07
Payout ratio 478.30%
Dividend date 309 May 2024
Ex-dividend date 429 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -201.16%
Operating margin (ttm)51.38%

Management effectiveness

Return on assets (ttm)-0.69%
Return on equity (ttm)-3.63%

Income statement

Revenue (ttm)320.82k
Revenue per share (ttm)0.26
Quarterly revenue growth (yoy)-76.40%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-645.35k
Diluted EPS (ttm)-0.53
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)204.19k
Total cash per share (mrq)0.17
Total debt (mrq)10.3M
Total debt/equity (mrq)64.96%
Current ratio (mrq)0.09
Book value per share (mrq)13.62

Cash flow statement

Operating cash flow (ttm)11.86M
Levered free cash flow (ttm)4.09M